DOI QR코드

DOI QR Code

Rho-Associated Kinase 2 Polymorphism in Patients With Vasospastic Angina

  • Yoo, Sang-Yong (Division of Cardiology, Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Kim, Jeong-Uk (Division of Cardiology, Department of Laboratory Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Cheong, Sang-Sig (Division of Cardiology, Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Shin, Dae-Hee (Division of Cardiology, Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Jang, Jin-Kun (Division of Cardiology, Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Lee, Chang-Kun (Division of Cardiology, Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Tahk, Seung-Jea (Division of Cardiology, Department of Internal Medicine, Ajou University College of Medicine) ;
  • Shin, Joon-Han (Division of Cardiology, Department of Internal Medicine, Ajou University College of Medicine) ;
  • Choi, So-Yeon (Division of Cardiology, Department of Internal Medicine, Ajou University College of Medicine) ;
  • Yoon, Myeong-Ho (Division of Cardiology, Department of Internal Medicine, Ajou University College of Medicine)
  • Published : 2012.06.30

Abstract

Background and Objectives: Recent studies indicate that in response to vasoconstrictor stimuli, the small GTPase RhoA and its downstream effector, Rho-associated kinase 2 (ROCK)/Rho-kinase, are associated with hypercontraction of the vascular smooth muscle of coronary arteries through augmentation of myosin light chain phosphorylation and $Ca^{2+}$ sensitization. Expression of ROCK/Rho-kinase mRNA was significantly increased and up-regulated in the spastic coronary artery in a porcine model, and a specific inhibitor of ROCK/Rho-kinase inhibited coronary artery spasm in humans. We therefore explored the role of ROCK2 polymorphisms in the pathogenesis of vasospastic angina (VA). Subjects and Methods: We studied 106 patients with VA who exhibited spontaneous or provoked coronary spasm during coronary angiography and compared the prevalence of ROCK2 polymorphisms between this group of patients with VA and controls whose angiograms were normal, and in whom the ergonovine test did not cause spasm (n=107). Five single nucleotide polymorphisms (SNPs) of the ROCK2 gene were selected. SNPs were genotyped by high-resolution melting. Linkage disequilibrium and haplotype analyses were performed using the SHEsis program. Results: The prevalence of genotypes of the 5 interesting SNPs in patients with VA was not different from that in the control group. In haplotype analysis, the haplotype G-T-C-T-G (in order of rs978906, rs2271621, rs2230774, rs1515210, and rs3771106) was significantly associated with a decreased risk of VA (p=0.007). Conclusion: The haplotype G-T-C-T-G in the ROCK2 gene had a protective effect against VA, suggesting the involvement of ROCK2 in VA pathogenesis.

Keywords

References

  1. Sueda S, Kohno H, Fukuda H, Uraoka T. Did the widespread use of longacting calcium antagonists decrease the occurrence of variant angina? Chest 2003;124:2074-8. https://doi.org/10.1378/chest.124.6.2074
  2. Yoo SY, Shin DH, Jeong JI, et al. Long-term prognosis and clinical characteristics of patients with variant angina. Korean Cir J 2008;38: 651-8. https://doi.org/10.4070/kcj.2008.38.12.651
  3. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm: clinical features, diagnosis, pathogenesis, and treatment. J Cardiol 2008;51:2-17. https://doi.org/10.1016/j.jjcc.2008.01.001
  4. Chahine RA, Raizner AE, Ishimori T, Luchi RJ, McIntosh HD. The incidence and clinical implications of coronary artery spasm. Circulation 1975:52:972-8. https://doi.org/10.1161/01.CIR.52.6.972
  5. Liew M, Pryor R, Palais R, et al. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin Chem 2004;50:1156-64. https://doi.org/10.1373/clinchem.2004.032136
  6. Reed GH, Wittwer CT. Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clin Chem 2004;50:1748-54. https://doi.org/10.1373/clinchem.2003.029751
  7. Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem 2003;49(6 Pt 1):853-60. https://doi.org/10.1373/49.6.853
  8. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-86.
  9. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97-8. https://doi.org/10.1038/sj.cr.7290272
  10. Li Z, Zhang Z, He Z, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009;19:519-23. https://doi.org/10.1038/cr.2009.33
  11. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-9. https://doi.org/10.1126/science.1069424
  12. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001;22:32-9. https://doi.org/10.1016/S0165-6147(00)01596-0
  13. Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001;81:153-208.
  14. Noma K, Oyama N, Liao JK. Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol 2006;290:C661-8.
  15. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003;4:446-56. https://doi.org/10.1038/nrm1128
  16. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK- I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 1996;392:189-93. https://doi.org/10.1016/0014-5793(96)00811-3
  17. Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol 2002;39:319-27. https://doi.org/10.1097/00005344-200203000-00001
  18. Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J 2000;64:1-12. https://doi.org/10.1253/jcj.64.1
  19. Kandabashi T, Shimokawa H, Miyata K, et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation 2000; 101:1319-23. https://doi.org/10.1161/01.CIR.101.11.1319
  20. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002;105:1545-7. https://doi.org/10.1161/hc1002.105938
  21. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994;372:231-6. https://doi.org/10.1038/372231a0
  22. Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998;273: 24266-71. https://doi.org/10.1074/jbc.273.37.24266
  23. Wolfrum S, Dendorfer A, Rikitake Y, et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 2004; 24:1842-7. https://doi.org/10.1161/01.ATV.0000142813.33538.82
  24. Kamiunten H, Koike J, Mashiba J, Shimokawa H, Takeshita A. A comprehensive analysis of a novel missense mutation in Rho-kinase that causes coronary vasospasm in the Japanese. Circ J 2004;68(suppl I): 211. Abstract.
  25. Yoo SY, Kim JY. Recent insights into the mechanisms of vasospastic angina. Korean Circ J 2009;39:505-11. https://doi.org/10.4070/kcj.2009.39.12.505
  26. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-9. https://doi.org/10.1161/01.CIR.87.1.76

Cited by

  1. The genetic basis for survivorship in coronary artery disease vol.4, pp.None, 2013, https://doi.org/10.3389/fgene.2013.00191
  2. Structural and Functional Coronary Artery Abnormalities in Patients With Vasospastic Angina Pectoris vol.79, pp.7, 2015, https://doi.org/10.1253/circj.cj-15-0520
  3. Rho Kinases in Health and Disease: From Basic Science to Translational Research vol.67, pp.4, 2015, https://doi.org/10.1124/pr.115.010595
  4. RhoGTPase in Vascular Disease vol.8, pp.6, 2012, https://doi.org/10.3390/cells8060551